Dr. Clifford Hudis discusses what’s new with chemotherapy trials at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. He reviews eight posters from the conference that explored various chemotherapy-related questions. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill-Cornell Medical College [...]

  Dr. Clifford Hudis, through his discussion of the trial showing bevacizumab (Avastin) slows metastatic breast cancer, he highlights the important topic of the value of progression-free survival (PFS). This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer Medicine Service at Memorial Sloan [...]

  Dr. Clifford Hudis discusses brain metastasis and a clinical trial ongoing at Memorial Sloan Kettering Cancer Center where researchers are testing chemotherapy penetration to the brain in a select group of trial-qualifying patients. This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Hudis is the Chief, Breast Cancer [...]

  Dr. Hope Rugo discusses the chemotherapy agent, Eribulin and the results of a recent study focused on breast cancer patients with advanced disease. We also question if she thinks this is the end for chemotherapy agents in the treatment of breast cancer? This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast [...]

  Dr. Hope Rugo discusses the chemotherapy agent, Eribulin and the results of a recent study focused on breast cancer patients with advanced disease. We also question if she thinks this is the end for chemotherapy agents in the treatment of breast cancer? This interview was conducted at the 34th Annual CTRC-AACR San Antonio Breast [...]

  Dr. Ann Partridge discusses the differences, biologically, medically, and emotionally, in young women with breast cancer as compared to older women with breast cancer at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Partridge is the Clinical Director, Breast Oncology Center and Director, Program For Young Women With Breast Cancer at the [...]

  Dr. Martine Piccart, the current president of the European Society for Medical Oncology (ESMO), talks about the data-sharing database of breast cancer trial information that ESMO in currently building and what is needed from patients to help continue the momentum. Dr. Piccart is Professor of Oncology at the Université Libre de Bruxelles (ULB) and [...]

  Dr. Martine Piccart, the current president of the European Society for Medical Oncology (ESMO), talks about the upcoming IMPAKT breast cancer meeting being held in Brussels, Belgium May 3-5, 2012. Dr. Piccart is Professor of Oncology at the Université Libre de Bruxelles (ULB) and Director of the Medicine Department at the Institut Jules Bordet, [...]

  Dr. Stefan Gluck, a Miami-based medical oncologist who deals with not only breast cancer, but a diverse Hispanic community, discusses data released at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium by Dr. Kathy Baumgartner showing that Latinas are about 20 percent more likely to die from breast cancer than non-Hispanic white women. [...]

  Dr. Stefan Gluck discusses the Avastin (bevacizumab) and how it has been shown to improve progression-free survival in HER2-Positive Breast Cancer in the AVEREL Study presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. Dr. Gluck is a Professor of Medicine, University of Miami, Associate Division Chief for Clinical Affaris, Division of [...]